<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Interleukin-7 Modulates Anti-Tumor CD8 + T Cell Responses via Its Action on Host Cells</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-07-22">July 22, 2016</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Katrin</forename><surname>Deiser</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Institute of Molecular and Clinical Immunology</orgName>
								<orgName type="department" key="dep2">Medical Faculty</orgName>
								<orgName type="institution">Otto-von-Guericke University</orgName>
								<address>
									<postCode>39120</postCode>
									<settlement>Magdeburg, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Institute of Immunology</orgName>
								<orgName type="institution">Charité-Universitaetsmedizin Berlin</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin</addrLine>
									<postCode>12200</postCode>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Diana</forename><surname>Stoycheva</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Institute of Molecular and Clinical Immunology</orgName>
								<orgName type="department" key="dep2">Medical Faculty</orgName>
								<orgName type="institution">Otto-von-Guericke University</orgName>
								<address>
									<postCode>39120</postCode>
									<settlement>Magdeburg, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Institute of Immunology</orgName>
								<orgName type="institution">Charité-Universitaetsmedizin Berlin</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin</addrLine>
									<postCode>12200</postCode>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ute</forename><surname>Bank</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Institute of Molecular and Clinical Immunology</orgName>
								<orgName type="department" key="dep2">Medical Faculty</orgName>
								<orgName type="institution">Otto-von-Guericke University</orgName>
								<address>
									<postCode>39120</postCode>
									<settlement>Magdeburg, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><surname>Blankenstein</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Immunology</orgName>
								<orgName type="institution">Charité-Universitaetsmedizin Berlin</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin</addrLine>
									<postCode>12200</postCode>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Max-Delbrück-Center for Molecular Medicine</orgName>
								<address>
									<postCode>13125</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Thomas</forename><surname>Schüler</surname></persName>
							<email>thomas.schueler@med.ovgu.de</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Institute of Molecular and Clinical Immunology</orgName>
								<orgName type="department" key="dep2">Medical Faculty</orgName>
								<orgName type="institution">Otto-von-Guericke University</orgName>
								<address>
									<postCode>39120</postCode>
									<settlement>Magdeburg, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Institute of Immunology</orgName>
								<orgName type="institution">Charité-Universitaetsmedizin Berlin</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin</addrLine>
									<postCode>12200</postCode>
									<settlement>Berlin, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="institution">Ohio State University</orgName>
								<address>
									<country key="US">UNITED STATES</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Interleukin-7 Modulates Anti-Tumor CD8 + T Cell Responses via Its Action on Host Cells</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-07-22">July 22, 2016</date>
						</imprint>
					</monogr>
					<idno type="MD5">B1999CEEBF85303FD224F28D85FC809C</idno>
					<idno type="DOI">10.1371/journal.pone.0159690</idno>
					<note type="submission">Received: March 21, 2016 Accepted: July 5, 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:23+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>The adoptive transfer of antigen-specific CD8 + T cells is a promising approach for the treatment of chronic viral and malignant diseases.</s><s>In order to improve adoptive T cell therapy (ATT) of cancer, recent strategies aim at the antibody-based blockade of immunosuppressive signaling pathways in CD8 + T cells.</s><s>Alternatively, adjuvant effects of immunostimulatory cytokines might be exploited to improve therapeutic CD8 + T cell responses.</s><s>For example, Interleukin-7 (IL-7) is a potent growth, activation and survival factor for CD8 + T cells that can be used to improve virus-and tumor-specific CD8 + T cell responses.</s><s>Although direct IL-7 effects on CD8 + T cells were studied extensively in numerous models, the contribution of IL-7 receptor-competent (IL-7R + ) host cells remained unclear.</s><s>In the current study we provide evidence that CD8 + T cell-mediated tumor rejection in response to recombinant IL-7 (rIL-7) therapy is strictly dependent on IL-7R + host cells.</s><s>On the contrary, CD8 + T cell expansion is independent of host IL-7R expression.</s><s>If, however, rIL-7 therapy and peptide vaccination are combined, host IL-7R signaling is crucial for CD8 + T cell expansion.</s><s>Unexpectedly, maximum CD8 + T cell expansion relies mainly on IL-7R signaling in non-hematopoietic host cells, similar to the massive accumulation of dendritic cells and granulocytes.</s><s>In summary, we provide evidence that IL-7R + host cells are major targets of rIL-7 that modulate therapeutic CD8 + T cell responses and the outcome of rIL-7-assisted ATT.</s><s>This knowledge may have important implications for the design and optimization of clinical ATT protocols.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>The size of the peripheral T cell pool is remarkably stable throughout life.</s><s>Although infections can cause a strong increase in T cell numbers, they usually return to steady-state levels after pathogen clearance.</s><s>This indicates that self-regulatory mechanisms maintain T cell numbers <ref type="bibr" target="#b0">[1]</ref>.</s><s>A central factor controlling peripheral T cell homeostasis is IL-7.</s><s>It acts as a growth and survival signal for T cells, which express the IL-7R and constitutively consume IL-7 <ref type="bibr" target="#b1">[2]</ref>.</s><s>Consequently, the size of the peripheral T cell pool becomes self-limiting as soon as IL-7 production and consumption reach an equilibrium <ref type="bibr" target="#b0">[1]</ref>.</s><s>Due to the lack of IL-7 consumption by T cells, IL-7 availability is increased in lymphopenic humans <ref type="bibr" target="#b2">[3]</ref> and mice <ref type="bibr" target="#b3">[4]</ref>.</s><s>Lymphopenia-associated IL-7 overabundance contributes to the activation of naïve T cells, which undergo homeostatic or lymphopenia-induced proliferation (LIP) and convert into memory-like cells, which express high levels of CD44 and IFNγ <ref type="bibr" target="#b4">[5]</ref>.</s></p><p><s>The adoptive transfer of antigen-specific T cells is an important therapeutic option for the treatment of viral infections and cancer and has been performed successfully in animal models as well as in the clinic <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b6">7]</ref>.</s><s>It is well established that the efficacy of adoptive T cell therapy (ATT) can be improved if recipient T cells are depleted by chemotherapy or irradiation prior to T cell transfer <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b7">8]</ref>.</s><s>This positive effect of lymphodepletion results from the increased availability of T cell growth and survival factors such as IL-7 <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10]</ref>.</s></p><p><s>From our own experiments we know that thymus, lymph nodes, skin and intestine are the major sources of IL-7 in the mouse <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b11">12]</ref>.</s><s>Nevertheless, steady-state IL-7 production is not sufficient for effective anti-tumor T cell responses under non-lymphopenic conditions.</s><s>The injection of recombinant IL-7 (rIL-7) circumvents this problem and boosts anti-tumor T cell responses <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b13">14]</ref>.</s><s>Since IL-7 promotes T cell survival <ref type="bibr" target="#b14">[15,</ref><ref type="bibr" target="#b15">16]</ref>, activation <ref type="bibr" target="#b16">[17,</ref><ref type="bibr" target="#b17">18]</ref>, proliferation <ref type="bibr" target="#b18">[19]</ref> and memory T cell (T M ) formation <ref type="bibr" target="#b19">[20]</ref> its direct action on T cells is supposed to be the major cause for its potent anti-tumor effects <ref type="bibr" target="#b20">[21]</ref>.</s><s>For the effective treatment of viral infections and cancer by ATT high numbers of adoptively transferred CD8 + cells are required in vivo <ref type="bibr" target="#b6">[7]</ref>.</s><s>Their longevity and subsequent accumulation can be improved by rIL-7 therapy suggesting that this approach can be used to improve ATT <ref type="bibr" target="#b20">[21]</ref>.</s><s>Importantly, the adjuvant effects of rIL-7 correlate with tumor growth delay rather than complete rejection <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b22">23]</ref>.</s><s>Given that i) regulatory immune cells such as dendritic cells (DCs) and granulocytes expand in response to elevated IL-7 levels <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b24">25]</ref> and ii) non-hematopoietic cells such as fibroblasts and intestinal epithelial cells express functional IL-7 receptors (IL-7R) <ref type="bibr" target="#b11">[12,</ref><ref type="bibr" target="#b25">26]</ref>, we hypothesized that IL-7R + host cells might modulate anti-tumor CD8 + T cell responses.</s></p><p><s>In the current study we asked whether and how host IL-7R signaling affects ATT efficacy.</s><s>For this purpose we established an ATT model, which enabled us to discriminate between direct and indirect effects of rIL-7 therapy on tumor-specific CD8 + T cells.</s><s>Our data demonstrate, that LIP of CD8 + T cells and subsequent T M differentiation are promoted by rIL-7 in a host IL-7R-independent manner.</s><s>However, tumor rejection strictly requires host IL-7R expression.</s><s>Furthermore, we show that IL-7R + non-hematopoietic host cells are crucial for maximum CD8 + T cell expansion and T M differentiation if rIL-7 therapy is combined with peptide vaccination.</s><s>Importantly, despite efficient CD8 + T cells expansion, peptide vaccination deteriorates rIL-7-dependent ATT efficacy.</s><s>In summary, we provide evidence that host IL-7R signaling modulates multiple aspects of CD8 + T cells activation and T M differentiation and can promote tumor rejection in a context-dependent fashion.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mice</head><p><s>C57BL/6J (WT), B6.PL-Thy1a/Cy (CD90.1 + ), B6.SJL-Ptprc a Pepc b /BoyJ (CD45.1 + ), B6.129S7-Rag1 tm1Mom /J (Rag -/-), B6.129S7-Il7r tm1Imx /J (IL-7R -/-), C57BL/6-Tg(TcraTcrb) 1100Mjb/J (OT-I) (expressing a transgenic TCR specific for the chicken ovalbumin (OVA)derived, H2-K b -restricted peptide OVA 257-264 (SIINFEKL)), IL-7GCDL <ref type="bibr" target="#b10">[11]</ref> and ChRluc mice <ref type="bibr" target="#b26">[27]</ref> were bred in our animal facilities.</s><s>All mice were housed under specific pathogen-free conditions.</s><s>Animal experiments were performed according to institutional guidelines and were approved by the Landesamt für Gesundheit und Soziales Berlin (Permit Number: G0170/08) and Landesverwaltungsamt Sachsen-Anhalt (Permit Number: 2-1155 Uni MD).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Generation of bone marrow (BM) chimeras and bioluminescence detection</head><p><s>BM recipients were anesthetized (Ketamin/Rompun i.p.), irradiated lethally and injected with BM cells i.v.</s><s>6-18 hours later.</s><s>Donor BM was isolated from femur and tibia.</s><s>BM from one donor was used to reconstitute 3 recipients.</s><s>BM chimeras received antibiotics via the drinking water for 3-4 weeks and were used for experiments earliest 6 weeks after BM injection.</s><s>To visualize luciferase activity in live animals, bioluminescence intensities (BLI) were measured using the IVIS Imaging system (Xenogen) as described before <ref type="bibr" target="#b10">[11,</ref><ref type="bibr" target="#b26">27]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Adoptive T cell transfer, peptide vaccination and IL-7 treatment</head><p><s>Naïve CD8 + T cells were purified from spleen and lymph nodes of the respective donor mice using CD8α-specific microbeads and AutoMACS (Miltenyi Biotec).</s><s>7 x 10 5 -1 x 10 6 CD8 + T cells (purity &gt;97%) were injected i.v.</s><s>into the tail vein of recipient mice.</s><s>For peptide vaccination, 50 μg of SIINFEKL were injected i.v.</s><s>one day after T cell transfer.</s><s>Control animals were injected with Dulbecco's PBS.</s><s>Prior to injection, recombinant murine IL-7 (rIL-7) (eBioscience) and anti-IL-7 mAb (M25; BioXCell) were mixed and incubated for 20 min at RT. Unless otherwise stated, 200 μl of 1,5 μg rIL-7 and 10 μg anti-IL-7 mAb in PBS were injected i.p every 3-4 days starting one day prior to T cell transfer.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Tumor cell challenge</head><p><s>EG7 lymphoma cells produce chicken ovalbumin (OVA) and are targets of CD8 + OT-I T cells.</s><s>EG7 cells were cultured in RPMI+10% FCS medium with 0.4 mg/ml G418. 1 x 10 6 cells were injected s.c. in the right flank of the indicated mice.</s><s>Mice with tumors &gt;250 mm 3 were scored as tumor positive.</s><s>Tumor growth was monitored every 2-3 days.</s><s>Mice were euthanized by cervical dislocation when tumors reached a diameter of 10-15 mm or when showing the following signs: hunched posture, inactivity, worsening body condition, rough coat, orbital tightening or abnormal breathing.</s><s>Body weight was not assessed in this study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Flow cytometry</head><p><s>The following antibodies were used: anti-CD8α (53-6.7;</s><s>eBioscience/Biolegend/BD), -CD90.1 (OX-7; Biolegend/BD), -CD62L (MEL-14; Biolegend/BD), -CD44 (IM7; eBioscience/Biolegend/BD), -KLRG-1 (2F1; eBioscience), PD-1 (J43; eBioscience), -Ki67 (SolA15; eBioscience), CD127 (A7R34; BD/Biolegend), CD132 (TUGm2; BD), -Bcl-2 (10C4; Biolegend), -IFN-γ (XMG1.2;</s><s>Biolegend/eBioscience), -TNF-α (MP6-XT22; BD), -CD11c (N418; BD/Biolegend), -CD11b (MI70; BD/Biologend), Gr-1 (RB6-8-C5; Biolegend).</s><s>Stimulation of CD8 + OT-I T cells with SIINFEKL and subsequent intracellular cytokine staining was performed as described recently <ref type="bibr" target="#b27">[28]</ref>.</s><s>Samples were measured on FACSCalibur, FACSCanto or LSRII flow cytometers and analyzed by FlowJo software (FlowJo, LLC).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Statistical analysis and graphical representations were done using Prism5 software (GraphPad Software).</s><s>Statistical significance was determined using a non-parametric two-tailed Mann-Whitney, paired Student's t, 1-and 2-way Anova, log-rank or Wilcoxon matched-pairs signed rank test.</s><s>Ã p&lt;0,05; ÃÃ p&lt;0,01; ÃÃÃ p&lt;0,001.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Host IL-7R signaling is crucial for rIL-7-dependent, CD8 + T cell-mediated tumor rejection Naïve CD8 + T cells transferred into lymphopenic mice undergo lymphopenia-induced proliferation (LIP), differentiate into CD44 hi memory-like T cells <ref type="bibr" target="#b4">[5]</ref> and limit tumor growth <ref type="bibr" target="#b7">[8]</ref>.</s><s>Accordingly, naive CD8 + TCR-transgenic (tg) OT-I T cells specific for the chicken ovalbumin (OVA)-derived, H2-K b -restricted peptide SIINFEKL, expanded and up regulated CD44 in lymphopenic Rag1-deficient (Rag -/-) recipients within 21-27 days after transfer.</s><s>Expansion and T M differentiation were not observed in OT-I-reconstituted, non-lymphopenic wildtype (WT) mice (S1 Fig) <ref type="figure">.</ref></s><s>Whether LIP-associated CD8 + T cell activation leads to tumor growth inhibition was tested next.</s><s>Twenty-two days after reconstitution with naive CD8 + OT-I T cells, Rag -/mice were challenged s.c. with 10 6 OVA-expressing EG7 lymphoma cells.</s><s>EG7 tumors grew rapidly in untreated Rag -/mice while adoptive T cell transfer strongly delayed tumor growth (Fig <ref type="figure" target="#fig_0">1A</ref>).</s><s>Nevertheless, only 1 mouse out of 11 remained long-term tumor-free.</s></p><p><s>In order to investigate whether IL-7 therapy promotes tumor rejection, groups of OT-Ireconstituted Rag -/mice received rIL-7 every 3-4 days for 18 days starting one day prior to adoptive T cell transfer.</s><s>To improve its function, rIL-7 was complexed with IL-7-specific antibodies (αIL-7) prior to injection as described before <ref type="bibr" target="#b28">[29]</ref>.</s><s>7/12 Rag -/mice receiving OT-I T cells plus IL-7 therapy completely rejected EG7 lymphoma cells demonstrating that IL-7 therapy strongly enhances OT-I-dependent tumor rejection in our experimental system (Fig <ref type="figure" target="#fig_0">1A</ref>).</s><s>Importantly, rIL-7 treatment did not affect primary EG7 growth in either host (data not shown).</s><s>Several studies provided evidence that rIL-7 promotes activation, survival, function of CD8 + T cells <ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b29">30</ref>] and memory T cell (T M ) formation <ref type="bibr" target="#b19">[20]</ref>.</s><s>So far, however, these effects were considered to result from direct effects of rIL-7 on CD8 + T cells.</s><s>Besides CD8 + T cells, however, numerous hematopoietic and non-hematopoietic cells express the IL-7 receptor (IL-7R) <ref type="bibr" target="#b30">[31]</ref>.</s><s>Hence, it remained unclear whether the success of IL-7-assisted adoptive T cell transfers relies on IL-7R signaling in CD8 + T cells and/or host cells.</s><s>In order to address this question, Rag -/mice lacking the IL-7Rα chain (Rag -/-IL-7R -/-) were reconstituted with OT-I T cells, received IL-7 therapy or PBS and were challenged with EG7 lymphoma cells.</s><s>This approach allowed us to separate direct from indirect effects of rIL-7 on CD8 + T cell-mediated lymphoma rejection.</s><s>As compared to untreated controls, OT-I cells strongly delayed tumor growth in Rag -/-IL-7R -/recipients ( In conclusion, host IL-7R signaling is dispensable for rIL-7-driven CD8 + T cell expansion (Fig 1C <ref type="figure">)</ref> but not for subsequent tumor rejection.</s><s>This highlights that high numbers of therapeutic CD8 + T cells do not necessarily correlate with therapeutic success.</s></p><p><s>Host IL-7R signaling is not required for rIL-7-induced T M differentiation but for granulocyte and DC expansion CD8 + T M express high levels of CD127 and the anti-apoptotic molecule B cell lymphoma protein-2 (Bcl-2) <ref type="bibr" target="#b32">[33]</ref>, which can be up regulated by IL-7 <ref type="bibr" target="#b33">[34]</ref>.</s><s>In PBS-treated Rag -/mice CD127 hi and Bcl-2 hi OT-I T M were less frequent than in Rag -/-IL-7R -/mice (Fig 2A <ref type="figure" target="#fig_8">and 2B</ref>).</s><s>In response to rIL-7 treatment, however, resulting OT-I T M expressed elevated levels of CD127 and Bcl-2 in both hosts <ref type="bibr" target="#b20">21</ref> After rIL-7 treatment, spleen cell numbers increased dramatically in Rag -/mice (Fig <ref type="figure" target="#fig_5">3A</ref>).</s><s>In agreement with previous studies <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b24">25]</ref>, CD11b + Gr-1 + granulocytes and CD11c + MHCII + DCs expanded most efficiently in response to rIL-7 (Fig 3B <ref type="figure" target="#fig_5">and 3C</ref>).</s><s>Among the latter, CD8 + lymphoid and CD8myeloid DCs responded similarly well (Fig 3D <ref type="figure" target="#fig_5">and 3E</ref>).</s><s>In Rag -/-IL-7R -/mice rIL-7 therapy failed to induce the expansion of splenocytes, granulocytes and DCs (Fig 3A <ref type="figure" target="#fig_5">-3E</ref>) excluding IL-7R-independent side effects of our treatment regimen.</s><s>In summary, host IL-7R signaling is crucial for rIL-7-induced, CD8 + T cell-mediated tumor rejection ( Host IL-7R signaling promotes CD8 + T cell expansion and modulates T M differentiation in response to peptide vaccination and IL-7 therapy IL-7 administration improves vaccination-induced T cell responses <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b21">22]</ref>.</s><s>To test whether this also requires host IL-7R signaling, Rag -/and Rag -/-IL-7R -/mice were reconstituted with OT-I cells, immunized with SIINFEKL and treated with rIL-7.</s><s>Peptide-vaccinated mice receiving PBS served as controls.</s><s>As shown in Fig 4A <ref type="figure" target="#fig_12">rIL-7</ref> treatment strongly increased spleen cell numbers in Rag -/but not Rag -/-IL-7R -/mice.</s><s>Furthermore, rIL-7 treatment promoted OT-I cell expansion in Rag -/mice (Fig <ref type="figure" target="#fig_6">4B</ref>).</s><s>Although to a much lesser extent, this was also observed in rIL-7-treated Rag -/-IL-7R -/mice (Fig <ref type="figure" target="#fig_6">4B</ref>).</s><s>Thus, IL-7R signaling in CD8 + T cells promotes some degree of rIL-7-induced CD8 + T cell expansion although the full-blown response requires host IL-7R expression.</s></p><p><s>To test whether IL-7R + host cells also modulate T M differentiation the phenotype of peripheral blood OT-I cells was determined by flow cytometry.</s><s>In Rag -/and Rag -/-IL-7R -/mice, frequencies of CD62L hi OT-I cells were similar after vaccination (Fig <ref type="figure" target="#fig_6">4C</ref>).</s><s>This was further increased by rIL-7 and was independent of host IL-7R expression (Fig <ref type="figure" target="#fig_6">4C</ref>).</s><s>OT-I cells expressed similar levels of CD127 after vaccination of Rag -/and Rag -/-IL-7R -/mice.</s><s>To our surprise, rIL-7 therapy further promoted CD127 expression by OT-I cells only in Rag -/mice (Fig <ref type="figure" target="#fig_6">4D</ref>).</s><s>KLRG-1 hi OT-I cells were more frequent in vaccinated Rag -/-IL-7R -/than in Rag -/mice.</s><s>In both hosts their abundance decreased in response to rIL-7, though to a lesser extent in Rag -/-IL-7R -/mice (Fig <ref type="figure" target="#fig_6">4E</ref>).</s><s>After vaccination, OT-I proliferation was lower in Rag -/mice as shown by low numbers of Ki67 hi cells (Fig <ref type="figure" target="#fig_6">4F</ref>).</s><s>Bcl-2 expression was similar in vaccinated Rag -/and Rag -/-IL-7R -/mice and was up regulated by rIL-7 only in the latter (Fig <ref type="figure" target="#fig_6">4G</ref>).</s><s>In summary, the rIL-7-induced up-regulation of CD62L by OT-I cells was largely independent of IL-7R + host cells.</s><s>In contrast, host cells promoted the expansion of OT-I cells (Fig 4B <ref type="figure">)</ref> and modulated their expression of CD127, KLRG-1 and Bcl-2 in response to rIL-7 therapy (Fig 4D <ref type="figure" target="#fig_6">, 4E  and 4G</ref>).</s></p><p><s>After vaccination, OT-I cells isolated from Rag -/mice produced high levels of IFN-γ (Fig <ref type="figure" target="#fig_6">4H</ref>).</s><s>This response was less pronounced in Rag -/-IL-7R -/mice but could be improved by rIL-7 treatment (Fig <ref type="figure" target="#fig_6">4H</ref>).</s><s>Importantly, rIL-7 treatment could not further promote the generation of IFN-γ hi OT-I cells in Rag -/mice (Fig <ref type="figure" target="#fig_6">4H</ref>).</s><s>OT-I cells producing high levels of TNF-α were similarly frequent in Rag -/and Rag -/-IL-7R -/mice and further expanded in both hosts in response to rIL-7 treatment (Fig <ref type="figure" target="#fig_6">4I</ref>).</s><s>The expression of PD-1, a marker for dysfunctional T cells, was comparable for OT-I cells recovered from mice of both strains.</s><s>In agreement with a previous study <ref type="bibr" target="#b34">[35]</ref>, rIL-7 administration reduced PD-1 expression on OT-I cells in Rag -/mice (Fig <ref type="figure" target="#fig_6">4J</ref>).</s><s>Surprisingly, this was not the case in Rag -/-IL-7R -/mice (Fig 4J <ref type="figure">)</ref> indicating that IL-7R + host  cells determine the levels of PD-1 expression by CD8 + T cells.</s><s>Hence, immunomodulation by rIL-7 relies on complex interactions between IL-7R + host and therapeutic CD8 + T cells.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IL-7R + non-hematopoietic cells are crucial for CD8 + T cell expansion in response to vaccination and rIL-7 therapy</head><p><s>Prolonged exposure to elevated levels of IL-7 down modulates il-7 gene activity in non-BMderived cells <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b11">12]</ref>, which are the major source of IL-7 in vivo <ref type="bibr" target="#b19">[20]</ref>.</s><s>To determine whether non-hematopoietic cells respond to rIL-7 therapy, IL-7 reporter mice expressing luciferase under the control of the il-7 promoter <ref type="bibr" target="#b10">[11]</ref> were treated with rIL-7.</s><s>As a readout for il-7 gene activity, bioluminescence intensities (BLI) were determined before and after rIL-7 treatment.</s><s>As shown in S2 Fig, rIL-7 administration reduced il-7 promoter activity significantly demonstrating that IL-7-producing non-BM-derived cells indeed respond to rIL-7 therapy.</s></p><p><s>In order to study the relative contribution of IL-7R signaling in hematopoietic versus nonhematopoietic host cells to rIL-7-induced CD8 + T cell responses, we generated bone marrow (BM) chimeric mice.</s><s>Lethally irradiated CD45.1 + Rag -/mice received BM from CD45.1 + Rag -/-(R !</s><s>R chimeras) or CD45.2 + Rag -/-IL-7R -/mice (RR !</s><s>R chimeras).</s><s>Furthermore, lethally irradiated CD45.2 + Rag -/-IL-7R -/mice received BM from CD45.2 + Rag -/-IL-7R -/-(RR !</s><s>RR chimeras) or CD45.1 + Rag -/mice (R !</s><s>RR chimeras).</s><s>Flow cytometric analysis of CD45.1/.2-disparate</s><s>RR !</s><s>R and R !</s><s>RR chimeras revealed that donor BM contributed to the generation of around 97% of splenic CD11b + cells (data not shown).</s><s>BM-reconstituted mice received OT-I cells, vaccination and rIL-7 therapy as described above.</s><s>Three weeks after adoptive T cell transfer, we first quantified splenic CD11b + cells and DCs.</s><s>To our surprise, IL-7R expression by BM-derived cells was dispensable for CD11b + cell expansion if non-BMderived cells expressed the IL-7R (Fig 5A; R !</s><s>R vs RR !</s><s>R chimeras).</s><s>If, however, BMand non-BM-derived cells lacked the IL-7R, CD11b + cell expansion was strongly impaired (RR !</s><s>RR).</s><s>Only a partial recovery was observed if BM-derived cells produced the IL-7R (Fig 5A; R !</s><s>RR) suggesting that IL-7R signaling in BM-and non-BM-derived cells synergize to promote therapy-induced CD11b + cell expansion.</s><s>Similarly, the expansion of IL-7R-competent and -deficient DCs was comparable in Rag -/-BM recipients (R !</s><s>R vs RR !</s><s>R).</s><s>On the contrary, DC expansion was strongly impaired in RR !</s><s>RR chimeras and only partially recovered in R !</s><s>RR chimeras (Fig <ref type="figure" target="#fig_9">5B</ref>).</s><s>Hence, IL-7R signaling in non-BM cells is crucial for therapyassociated DC expansion.</s><s>However, this appeared to be more important for CD8 + DCs than for CD8 -DCs (Fig 5C <ref type="figure" target="#fig_9">and 5D</ref>).</s></p><p><s>Similar to DCs, OT-I accumulation in the spleen was independent of IL-7R expression by BM derived cells if non-BM-derived cells expressed the IL-7R ( IL-7 treatment is known to alter homing patterns of CD8 + T cells <ref type="bibr" target="#b35">[36]</ref>.</s><s>To exclude migration-related differences in splenic OT-I cell numbers, BM chimeras were reconstituted with renilla luciferase-transgenic (ChRluc tg ) CD8 + OT-I T cells <ref type="bibr" target="#b26">[27]</ref>, vaccinated and treated with (frequ.) of (C) CD62L hi , (E) KLRG-1 hi , (F) Ki67 hi , (H) IFN-γ hi , (I) TNF-α hi OT-I cells and relative MFIs for (D) CD127, (Γ) Bcl-2 and (J) PD-1 were determined.</s><s>(H, I) Cytokine production was measured after in vitro stimulation of PBMCs with 1 μM SIINFEKL peptide in the presence of Rag -/splenocytes, brefeldin A and monensin for 6 hours.</s><s>Relative (rel.)</s><s>values were calculated as described in</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IL-7R + non-BM cells modulate CD8 + T M differentiation in response to vaccination and rIL-7 therapy</head><p><s>Having shown that non-BM cells promote the expansion of CD8 + T cells, we analyzed their phenotype.</s><s>Three weeks after adoptive transfer, OT-I cells isolated from the spleens of BM chimeras were analyzed by flow cytometry.</s><s>In agreement with Fig 4E, KLRG-1 hi OT-I cells were more frequent in RR !</s><s>RR than in R !</s><s>R chimeras (Fig 6A <ref type="figure">)</ref> further emphasizing that T M differentiation into KLRG-1 hi cells is modulated by IL-7R + host cells.</s><s>These cells appear to be of BM and non-BM origin as shown by the fact that R !</s><s>RR chimeras contained most KLRG-1 hi OT-I cells.</s><s>However, their numbers were reduced in RR !</s><s>RR chimeras and lowest in R !</s><s>R and RR !</s><s>R chimeras (Fig <ref type="figure" target="#fig_10">6A</ref>).</s></p><p><s>The frequencies of CD62L hi OT-I cells were identical in R !</s><s>R and RR !</s><s>RR chimeras suggesting their host IL-7R-independence (Fig <ref type="figure" target="#fig_10">6B</ref>).</s><s>However, CD62L hi OT-I cells were less abundant in RR !</s><s>R and R !</s><s>RR (Fig <ref type="figure" target="#fig_10">6B</ref>).</s><s>This indicates that IL-7R + BM-and non-BM-derived cells are part of a complex network exerting opposing functions on CD62L hi T M differentiation.</s></p><p><s>Highest levels of CD127 were found on OT-I cells from R !</s><s>R and RR !</s><s>R chimeras and lowest on those from RR !</s><s>RR chimeras (Fig 6C <ref type="figure">)</ref> demonstrating that IL-7R expression by non-BM cells is a prerequisite for maximum CD127 expression by CD8 + T cells.</s><s>If only BMderived cells expressed the IL-7R (R !</s><s>RR) CD127 levels were significantly higher than in RR !</s><s>RR chimeras but still below those found on OT-I cells primed in RR !</s><s>R chimeras (Fig <ref type="figure" target="#fig_10">6C</ref>).</s><s>Thus, IL-7R + non-BM cells are major regulators of CD127 expression by OT-I cells.</s></p><p><s>The genes encoding Bcl-2 and CD8 are direct targets of IL-7 and other cytokines utilizing the IL-2Rγ c (CD132) for signal transduction <ref type="bibr" target="#b36">[37]</ref>.</s><s>CD127 lo OT-I cells from RR !</s><s>RR chimeras expressed highest levels of CD132, Bcl-2 and CD8 (Fig 6D <ref type="figure" target="#fig_10">-6F</ref>) suggesting that other CD132-dependent cytokines than IL-7 caused the differentiation of CD127 lo CD132 hi Bcl-2 hi CD8 hi T M cells in RR !</s><s>RR chimeras.</s><s>In contrast, R !</s><s>R and RR !</s><s>R chimeras rather contained CD127 hi CD132 lo Bcl-2 lo CD8 lo OT-I cells (Fig 6C <ref type="figure" target="#fig_10">-6F</ref>).</s><s>However, if only BM-derived cells expressed the IL-7R (R !</s><s>RR) we observed an intermediate OT-I phenotype (Fig 6C <ref type="figure" target="#fig_10">-6G  and 6F</ref>).</s></p><p><s>In response to rIL-7 treatment PD-1 was downregulated only on OT-I cells primed in Rag -/mice but not on those primed in Rag -/-IL-7R -/mice (Fig <ref type="figure" target="#fig_6">4J</ref>).</s><s>In agreement with this, PD-1 expression was most pronounced in RR !</s><s>RR chimeras (Fig <ref type="figure" target="#fig_10">6G</ref>).</s><s>PD-1 levels were significantly lower in both groups of chimeras expressing IL-7R on non-BM-derived cells and (R !</s><s>In summary, IL-7R + host cells promoted the expansion of CD8 + T M cells in response to rIL-7 therapy (Fig 4B <ref type="figure" target="#fig_6">-4J</ref>).</s><s>Surprisingly, regulatory host cells were mainly of non-BM origin (Figs <ref type="figure" target="#fig_10">5E, 5F and 6</ref>).</s></p><p><s>The combination of rIL-7 therapy and peptide vaccination impairs T celldependent tumor rejection in Rag -/mice CD8 + CD62L hi KLRG-1 lo IFN-γ hi PD-1 lo T M cells are well suited to provide long-term protection against chronic infections and tumors <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b37">38,</ref><ref type="bibr" target="#b38">39]</ref>.</s><s>Peptide vaccination and rIL-7 therapy induced the generation of such T M cells in Rag -/mice (Fig 4B <ref type="figure" target="#fig_6">-4J</ref>), a process that was mainly controlled by IL-7R + non-hematopoietic cells (Figs 5E, 5F and 6).</s><s>However, their therapeutic potential remained unclear.</s><s>To test this, Rag -/mice were reconstituted with CD8 + OT-I T cells and vaccinated with SIINFEKL one day later.</s><s>Additionally, mice received rIL-7 or PBS according to the scheme described above.</s><s>To ensure appropriate OT-I expansion and differentiation, mice were challenged with EG7 cells 21 days after adoptive T cell transfer.</s><s>In untreated Rag -/control mice, EG7 tumors grew rapidly (</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>The major goal of our study was to clarify whether and how host IL-7R signaling contributes to rIL-7-driven anti-tumor CD8 + T cell responses.</s><s>For this purpose, SIINFEKL-specific CD8 + OT-I cells were transferred into Rag -/and Rag -/-IL-7R -/mice, which were then treated with rIL-7.</s><s>As shown in Fig 1A <ref type="figure">,</ref> OT-I-reconstituted Rag -/mice receiving IL-7 therapy rejected SIINFEKL-expressing EG7 lymphoma cells.</s><s>This was not the case for Rag -/-IL-7R -/mice demonstrating that the success of rIL-7 therapy is dependent on host IL-7R expression in our experimental system.</s><s>However, CD8 + T cell expansion and differentiation were largely independent of host IL-7R signaling.</s><s>Irrespective of host IL-7R expression nearly identical numbers of OT-I cells were recovered from spleens after rIL-7 treatment.</s><s>Similarly, the differentiation of CD8 + T M with a CD127 hi Bcl-2 hi CD62L hi KLRG-1 lo IFN-γ hi phenotype was induced in rIL-7-treated Rag -/and Rag -/-IL-7R -/mice.</s><s>Hence, our data show that rIL-7-induced CD8 + T cell expansion and subsequent T M differentiation are not affected by host IL-7R expression and related differences in IL-7 availability (Fig <ref type="figure" target="#fig_0">1D</ref>).</s><s>In agreement with previous studies <ref type="bibr" target="#b20">[21]</ref>, the beneficial effects of rIL-7 on CD8 + T cell function, differentiation and survival appear to result mainly from IL-7R signaling in CD8 + T cells.</s><s>Nevertheless, it is important to stress that effective CD8 + T cell expansion and differentiation do not necessarily correlate with tumor rejection.</s><s>This conclusion is supported by the fact that rIL-7-induced OT-I expansion and subsequent T M differentiation occurred efficiently in Rag -/-IL-7R -/mice while tumor rejection failed.</s><s>This finding emphasizes the importance of IL-7-responsive host cells for rIL-7-assisted ATT in our model system.</s></p><p><s>Dendritic cells promote CD8 + T cell responses under lymphopenic conditions <ref type="bibr" target="#b39">[40]</ref>, crosspresent tumor-derived antigens <ref type="bibr" target="#b40">[41]</ref> and expand in response to rIL-7 treatment <ref type="bibr" target="#b23">[24]</ref>, which promotes T-DC interactions <ref type="bibr" target="#b41">[42]</ref>.</s><s>Additionally, rIL-7 stimulates myelopoiesis and the subsequent accumulation of CD11b + cells <ref type="bibr" target="#b24">[25]</ref>, which can cross-present tumor antigens and promote CD8 + T cell-mediated tumor rejection <ref type="bibr" target="#b42">[43]</ref>.</s><s>After rIL-7 treatment, DCs and granulocytes accumulated only in IL-7R-competent mice.</s><s>However, this accumulation was not required for expansion and functional maturation of OT-I cells but correlated positively with tumor rejection.</s><s>This suggests that rIL-7-expanded DCs and granulocytes support CD8 + T cell responses in the late effector phase rather than in the early phase after adoptive transfer.</s></p><p><s>IL-7R signaling in combination with TCR stimulation boosts CD8 + T cell responses in multiple experimental systems.</s><s>TCR signal strength and the timing of IL-7R signaling appear to be important to achieve optimal IL-7 effects <ref type="bibr" target="#b43">[44]</ref>.</s><s>To generate maximum CD8 + T cell responses, we reconstituted Rag -/and Rag -/-IL-7R -/mice with OT-I cells and vaccinated them with SIIN-FEKL.</s><s>Unlike after rIL-7 treatment alone, host IL-7R signaling was crucial for maximum OT-I expansion in response to vaccination and rIL-7.</s><s>Additionally, OT-I cells up-regulated CD127 and down-modulated PD-1 in a host-IL-7R-dependent fashion.</s><s>This was not the case for all other markers tested.</s><s>The host-dependent modulation of CD8 + T cell differentiation was confirmed in BM chimeras.</s><s>Surprisingly, we identified IL-7R + radio-resistant host cells as major regulators of CD8 + T cell expansion and differentiation.</s><s>For maximum levels of CD127 expression and restriction of KLRG-1, CD132, Bcl-2, CD8, and PD-1, IL-7R expression by radioresistant host cells was sufficient.</s><s>CD127 expression is modulated by multiple intracellular signaling events in T cells.</s><s>Whether non-BM-derived host cells affect these or other signaling pathways remains open.</s></p><p><s>Besides OT-I expansion and differentiation, IL-7R + non-BM-derived cells also controlled granulocyte and DC expansion.</s><s>Even if donor BM was devoid of the IL-7R, its expression by radio-resistant cells supported the expansion of CD11b + cells and DCs.</s><s>However, IL-7R expression by BM-derived cells was largely sufficient to rescue the expansion of CD11b + cells and CD8 -DCs.</s><s>Surprisingly, this was not the case for CD8 + DCs.</s><s>Their accumulation depended more on IL-7R expression by non-BM-than by BM-derived cells.</s><s>Together, we demonstrate that IL-7R signaling in BM-and non-BM-derived cells contributes to rIL-7-driven DC expansion.</s><s>This might help to reconcile apparently conflicting results regarding the relative importance of cell autonomous IL-7R signaling for DC generation obtained in different experimental systems <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b44">45]</ref>.</s></p><p><s>Fibroblastic reticular cells (FRCs) and lymphoid endothelial cells (LECs) are major sources of IL-7 in secondary lymphoid organs <ref type="bibr" target="#b45">[46]</ref>.</s><s>Furthermore, other cells of non-BM origin such as intestinal epithelial cells (IECs) <ref type="bibr" target="#b46">[47]</ref>, keratinocytes <ref type="bibr" target="#b47">[48]</ref>, hepatocytes <ref type="bibr" target="#b48">[49]</ref> and fibroblasts <ref type="bibr" target="#b49">[50]</ref> were shown to produce IL-7 in vivo.</s><s>The maintenance of CD8 + T cell homeostasis requires IL-7R signaling in CD8 + T cells which is triggered by IL-7 from non-BM derived cells <ref type="bibr" target="#b19">[20]</ref>.</s><s>However, only little is known about the consequences of IL-7R signaling in non-BM-derived cells and subsequent immune modulation <ref type="bibr" target="#b50">[51]</ref>.</s><s>As we have shown in S2 Fig, the application of rIL-7 leads to the systemic down-modulation of il-7 gene activity supporting previous reports demonstrating that il-7 gene activity is regulated in an IL-7-mediated negative feedback loop <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b11">12]</ref>.</s><s>Given that IL-7R signaling modulates gene expression profiles in multiple non-BM-derived cell types <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b25">26]</ref>, long-term rIL-7 therapy would not only affect immune cell but also nonimmune cell homeostasis.</s><s>For instance, prolonged IL-7 overabundance promotes IEC expansion, survival and subsequent alterations in intestinal physiology <ref type="bibr" target="#b11">[12]</ref>.</s><s>Since many cell types of non-BM-derived origin can express the IL-7R <ref type="bibr" target="#b30">[31]</ref>, the local down regulation of endogenous IL-7 production and alterations in tissue homeostasis might be as yet underestimated side effects of rIL-7 therapy.</s><s>Whether i) non-BM-derived cells located in the tumor stroma and/or other tissues are the main targets of rIL-7, and ii) whether rIL-7 signaling in such cells promotes or suppresses rIL-7-assisted ATT remains to be shown.</s></p><p><s>IL-7R + host cells appear to promote antigen-dependent CD8 + T cell function also in an IL-7-independent fashion.</s><s>For example, successful peptide vaccination and subsequent tumor rejection, in the absence of rIL-7 treatment, strictly required host IL-7R expression (Fig 7A <ref type="figure" target="#fig_12">and  7B</ref>).</s><s>Importantly, however, peptide vaccination blocked the therapeutic effect of rIL-7 (Figs 1A and 7A) in Rag -/mice although IL-7R-dependent DC expansion was normal (Fig <ref type="figure" target="#fig_12">7C</ref>).</s><s>It has been reported that TCR signaling can interfere with the beneficial effects of IL-7 on T cells <ref type="bibr" target="#b51">[52]</ref>.</s><s>Hence, impaired tumor rejection in rIL-7-treated, peptide vaccinated Rag -/mice might have been a result of altered T cell rather than host cell function.</s></p><p><s>In summary, our data provide evidence for the complex interplay between IL-7R + host and CD8 + T cells in the course of anti-tumor CD8 + T cell responses.</s><s>While productive host-CD8 + T cell interactions can be promoted by rIL-7 therapy, the inappropriate combination with other immune stimuli can cause adverse effects.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supporting Information</head></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig 1 .</head><label>1</label><figDesc><div><p><s>Fig 1. Host IL-7R signaling is required for CD8 + T cell-mediated tumor rejection in response to IL-7 treatment.</s><s>(A-C) Rag -/and Rag -/-IL-7R -/mice were reconstituted with 7-10 x 10 5 CD8 + CD90.1 + OT-I T cells or were left untreated (+/-OT-I).</s><s>OT-I-reconstituted mice received rIL-7 (+ IL-7) or PBS (-IL-7) every 3-4 days for 18 days starting one day before T cell transfer.</s><s>(A, B) 22-23 days after T cell transfer, some mice were challenged s.c. with 1 x 10 6 ovalbumin-expressing EG7 lymphoma cells.</s><s>Mice with tumors &gt;250 mm 3 were scored as tumor positive.</s><s>Pooled data from 2 independent experiments with a total of 10-12 mice per group are shown.</s><s>Statistical significance was calculated using the log-rank test.</s><s>(C, D) Some recipients were not challenged with EG7 but analyzed for OT-I expansion and phenotype.</s><s>(C) Splenic CD8 + CD90.1 + OT-I T cells were quantified 21-25 days after adoptive transfer.</s><s>Pooled data (±SEM) from 2 independent experiments with a total of 7-9 mice/group are shown.</s><s>(D) CD127 expression of splenic OT-I T cells was determined 5 days after adoptive transfer.</s><s>Data (±SEM) for 3-4 mice/group are shown.</s><s>doi:10.1371/journal.pone.0159690.g001</s></p></div></figDesc><graphic coords="4,205.68,394.81,282.95,193.44" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>Fig 1B) similar to what we had observed in Rag -/mice (Fig 1A).</s><s>This demonstrates that host IL-7R-deficiency does not limit LIP-associated CD8 + T M differentiation (S1 Fig) and subsequent anti-tumor immunity (Fig 1B).</s><s>In contrast to Rag -/mice, rIL-7 treatment of OT-Ireconstituted Rag -/-IL-7R -/mice did not improve anti-tumor CD8 + T cell responses (Fig 1B) indicating that direct effects of rIL-7 on CD8 + T cells are not sufficient for successful tumor rejection.</s><s>In fact, IL-7R signaling by host cells is crucial for tumor rejection after CD8 + T cell transfer and rIL-7 therapy.</s><s>Next we studied whether impaired tumor rejection in Rag -/-IL-7R -/mice resulted from reduced LIP.</s><s>Rag -/and Rag -/-IL-7R -/mice were reconstituted with CD8 + OT-I T cells and spleen cells were analyzed 21-27 days later.</s><s>CD44 levels (S1A Fig) and recovery rates (S1B Fig) did not differ between OT-I cells from Rag -/and Rag -/-IL-7R -/mice.</s><s>In conclusion, LIP-driven expansion and T M formation are independent of host IL-7R signaling.</s><s>To analyze the impact of host IL-7R signaling on rIL-7 therapy-related T M differentiation and expansion, Rag -/and Rag -/-IL-7R -/mice were reconstituted with OT-I T cells and treated with rIL-7 (+IL-7) or PBS (-IL-7) as described above.</s><s>In accordance with S1B Fig, similar numbers of OT-I cells were recovered from spleens of PBS-treated Rag -/and Rag -/-IL-7R -/mice 21-25 days after adoptive transfer (Fig 1C).</s><s>IL-7 signaling suppresses IL-7Rα chain (CD127) expression by naive T cells [32].</s><s>Accordingly, a strong and host-independent down-modulation of CD127 was observed 5 days after adoptive transfer and rIL-7 treatment (Fig 1D).</s><s>Importantly, OT-I T cells expressed less CD127 in PBS-treated Rag -/-IL-7R -/than in Rag -/mice arguing for elevated steady state IL-7 levels in the latter.</s><s>Nevertheless, this did not affect the long-term abundance (Fig 1C) or early rIL-7 responsiveness of OT-I T cells (Fig 1D).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>-25 days after transfer (Fig 2A and 2B).</s><s>Hence, despite early CD127 down-regulation (Fig 1D), IL-7 therapy promoted the generation of CD127 hi Bcl-2 hi OT-I T M irrespective of the host.</s><s>IL-7 therapy also promoted the generation of CD62L hi OT-I cells (Fig 2C) expressing low levels of KLRG-1 (Fig 2D).</s><s>Furthermore, a high percentage of OT-I cells recovered from both hosts rapidly produced IFN-γ after short-term in vitro re-stimulation (Fig 2E).</s><s>Hence, rIL-7 therapy favors the generation of functional CD8 + T M cells with a CD127 hi Bcl-2 hi CD62L hi KLRG-1 lo phenotype in a host-independent fashion.</s><s>Interestingly, despite their high numbers (Fig 1C) and favorable phenotype (Fig 2), rIL-7-induced OT-I T M cells failed to reject tumors in Rag -/-IL-7R -/mice (Fig 1B).</s><s>This suggested a contribution of rIL-7-responsive host cells to EG7 elimination.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head></head><label></label><figDesc><div><p><s>Fig 1A and 1B), is not essential for CD8 + T M differentiation (Fig 2) but promotes the expansion of granulocytes and DCs.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig 2 .</head><label>2</label><figDesc><div><p><s>Fig 2. Host IL-7R signaling is not required for rIL-7-induced T M differentiation.</s><s>(A-E) Rag -/and Rag -/-IL-7R -/mice were treated with rIL-7 or PBS (+/-IL-7) every 3-4 days starting one day prior to adoptive transfer of 1 x 10 6 CD8 + CD90.1 + OT-I T cells.</s><s>21-25 days after transfer, splenic OT-I T cells were analyzed by flow cytometry.</s><s>After gating on CD8 + CD90.1 + or CD8 + Vα2 + OT-I T cells, mean fluorescence intensities (MFIs) for (A) CD127 and (B) Bcl-2 as well as the frequencies (frequ.) of (C) CD62L hi , (D) KLRG-1 hi and (E) IFN-γ hi cells were determined.</s><s>IFN-γ production was measured after in vitro re-stimulation with 1 μM SIINFEKL peptide in the presence of brefeldin A for 6 hours.</s><s>(A-E) Data shown in bar diagrams were normalized to the mean values determined in PBS-treated Rag -/mice and are shown as relative (rel.)</s><s>values.</s><s>Pooled data (±SEM) from 2-3 independent experiments with a total of 7-13 mice/group are shown.</s><s>Histogram overlays show relative cell numbers (rel.</s><s>cell #) and relative fluorescence intensities (rel.</s><s>fl.</s><s>int.) for individual mice after gating on OT-I cells.</s><s>Dashed lines in overlays represent (A-D) FMO control samples or (E) stained cells without prior SIINFEKL stimulation.</s><s>doi:10.1371/journal.pone.0159690.g002</s></p></div></figDesc><graphic coords="6,200.01,78.01,324.00,222.92" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Fig 3 .</head><label>3</label><figDesc><div><p><s>Fig 3. Host IL-7R signaling is required for granulocyte and DC expansion in response to rIL-7.</s><s>Rag -/and Rag -/-IL-7R -/mice were treated with rIL-7 or PBS (+/-IL-7) every 3-4 days and spleens were analyzed by flow cytometry after 10-24 days.</s><s>(A-E) Shown are numbers of (A) splenocytes (Splen.),</s><s>(B) CD11b + Gr1 + granulocytes (Gran.),</s><s>(C) CD11c + MHC-II + dendritic cells (DCs), (D) CD8 + and (E) CD8 -DCs.</s><s>Shown are pooled data (±SEM) from 2 independent experiments with a total of 7-8 mice/group.</s><s>doi:10.1371/journal.pone.0159690.g003</s></p></div></figDesc><graphic coords="7,200.01,74.38,192.47,194.40" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Fig 4 .</head><label>4</label><figDesc><div><p><s>Fig 4. Host IL-7R signaling modulates CD8 + T cell expansion and differentiation in response to peptide vaccination and IL-7 therapy.</s><s>(A-J) Rag -/and Rag -/-IL-7R -/mice were reconstituted with CD8 + CD90.1 + OT-I T cells and treated with SIINFEKL +/-rIL-7 as described in Fig 4. Three weeks after T cell transfer (A, B) spleens and (C-J) peripheral blood were analyzed by flow cytometry.</s><s>Shown are numbers of (A) splenocytes and (B) splenic CD8 + CD90.1 + OT-I T cells.</s><s>After gating on OT-I T cells, relative frequencies</s></p></div></figDesc><graphic coords="8,200.01,78.01,233.41,576.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head></head><label></label><figDesc><div><p><s>Fig 5E; R !</s><s>R vs RR !</s><s>R).</s><s>In accordance with Fig 4B, OT-I responses were least efficient in chimeras lacking the IL-7R on BM-derived and non-BM-derived cells (Fig 5E; RR !</s><s>RR).</s><s>Importantly, IL-7R expression by BM-derived cells alone was insufficient to fully recover OT-I accumulation (Fig 5E; R !</s><s>RR).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>Fig 2 .</head><label>2</label><figDesc><div><p><s>Bar diagrams show pooled data (±SEM) from 3 independent experiments with a total of 15-18 mice/group.</s><s>Histogram overlays show representative results for individual mice.</s><s>Dashed lines in overlays represent (C-G and J) FMO control samples or (H, I) stained cells without prior SIINFEKL stimulation.</s><s>doi:10.1371/journal.pone.0159690.g004</s><s>rIL-7.</s><s>Six days later, whole-body BLI levels were determined to quantify relative OT-I cell numbers in an unbiased, tissue-independent fashion.</s><s>As shown in Fig 5F, ChRluc tg OT-I were similarly abundant in R !</s><s>R and RR !</s><s>R chimeras.</s><s>On the contrary, their frequency was strongly impaired in RR !</s><s>RR chimeras and only partially recovered in R !</s><s>RR chimeras.</s><s>Hence, these results confirm Fig 5E and further emphasize the importance of IL-7R + non-BM cells for rIL-7-induced CD8 + T cell expansion.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Fig 5 .</head><label>5</label><figDesc><div><p><s>Fig 5. IL-7R signaling in non-hematopoietic host cells contributes to granulocyte, DC and CD8 + T cell expansion in response to IL-7 therapy.</s><s>Lethally irradiated CD45.1 + Rag -/and CD45.2 + Rag -/-IL-7R -/mice were reconstituted with the indicated bone marrow (BM) cells (donor!recipient).</s><s>After successful BM reconstitution, BM chimeras received 1 x 10 6 CD8 + OT-I T cells.</s><s>One day later, mice were vaccinated with 50 μg SIINFEKL.</s><s>IL-7 treatment was done as described above.</s><s>(A-E) Three weeks after T cell transfer, recipient spleens were analyzed by flow cytometry and the numbers of the indicated cell types were determined.</s><s>Shown are pooled data (±SEM) of 3 independent experiments with a total of 10-17 mice/group.</s><s>(F) BM chimeras received 1 x 10 6 renilla luciferase-transgenic (ChRluc tg ) CD8 + OT-I T cells (OT-I ChRluc ) and were treated with SIINFEKL and rIL-7 as described above.</s><s>Six days after T cell transfer, mice were treated with 100 μg colenterazine to determine bioluminescence intensities (BLI) as a readout for OT-I abundance and distribution.</s><s>Shown are pooled results (±SEM) of 2 independent experiments with a total of 5-10 mice/ group.</s><s>doi:10.1371/journal.pone.0159690.g005</s></p></div></figDesc><graphic coords="10,200.01,78.01,297.81,182.15" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_10"><head>Fig 6 .</head><label>6</label><figDesc><div><p><s>Fig 6.</s><s>IL-7R signaling in non-hematopoietic cells regulates CD8 + T cell differentiation in response to peptide vaccination and IL-7 therapy.</s><s>(A-G) The indicated BM chimeras received CD8 + OT-I T cells and were treated with SIINFEKL and rIL-7 as described above.</s><s>Three weeks after T cell transfer, splenic CD8 + OT-I T cells were analyzed by flow cytometry.</s><s>Bar diagrams show pooled results (±SEM) of 2-3 independent experiments with a total of (A, B, C, E, G) 10-17 or (D) 4-10 mice/group.</s><s>Histogram overlays show representative results for individual mice.</s><s>Grey-lined histograms represent FMO staining controls.</s><s>doi:10.1371/journal.pone.0159690.g006</s></p></div></figDesc><graphic coords="11,200.01,72.17,317.03,342.71" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_11"><head></head><label></label><figDesc><div><p><s>Fig 7A).</s><s>In contrast, 6/12 peptide-vaccinated Rag -/mice remained tumor free (Fig 7A).</s><s>Surprisingly, however, only 2/12 Rag -/mice rejected EG7 lymphomas after rIL-7 therapy (Fig 7A).</s><s>Importantly, this was not due to impaired DC expansion in rIL-7-treated Rag -/mice (Fig 7C).</s><s>Hence, the protective effect of peptide vaccination was blunted by rIL-7.</s><s>Correlating with their comparably low frequency (Fig 4B) and KLRG-1 hi IFN-γ lo phenotype (Fig 4E and 4H), SIINFEKL-induced T M cells rejected EG7 tumors only in 2/12 Rag -/-IL-7R -/mice (Fig 7B).</s><s>After rIL-7 therapy only 1/12 Rag -/-IL-7R -/mice remained tumor free (Fig 7B).</s><s>In summary, the protective effect of peptide vaccination relied on host IL-7R signaling and was blunted by rIL-7 therapy.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_12"><head>Fig 7 .</head><label>7</label><figDesc><div><p><s>Fig 7. The combination of rIL-7 therapy and peptide vaccination impairs T cell-dependent tumor rejection in Rag -/mice.</s><s>(A) Rag -/and (B) Rag -/-IL-7R -/mice were reconstituted with 1 x 10 6 CD8 + CD90.1 + OT-I T cells or were left untreated (+/-OT-I).</s><s>One day later, OT-I-reconstituted mice were either vaccinated with 50 μg SIINFEKL or received PBS (+/-Pep).</s><s>rIL-7 or PBS (+/-IL-7) were injected every 3-4 days for 19 days starting one day before T cell transfer.</s><s>Mice were challenged s.c. with 1 x 10 6 EG7 tumor cells three weeks after T cell transfer.</s><s>Mice with tumors larger than 250 mm 3 were scored as tumor positive.</s><s>Shown are pooled data from 2 independent experiments with a total of 12-13 T cell reconstituted mice.</s><s>Primary tumor growth was analyzed in untreated Rag -/and Rag -/-IL-7R -/mice (n = 3).</s><s>Statistical significance was calculated using the log-rank test.</s><s>(C) The numbers of splenic DCs were determined in tumor-bearing mice 28-37 days after tumor challenge.</s><s>Pooled data (±SEM) from 2 independent experiments with a total of 6-11 mice/group are shown.</s><s>Statistical significance was calculated using the Mann-Whitney test.</s><s>doi:10.1371/journal.pone.0159690.g007</s></p></div></figDesc><graphic coords="12,200.01,504.28,365.73,105.56" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_13"><head>S1</head><label></label><figDesc><div><p><s>Fig. Lymphopenia-induced T cell proliferation (LIP) is independent of host IL-7R signaling.</s><s>(A, B) Rag -/-, Rag -/-IL-7R -/and WT mice were reconstituted with 1 x 10 6 CD8 +-CD90.1 + OT-I T cells.</s><s>Spleens were analyzed by flow cytometry 21-27 days later.</s><s>Shown are (A) relative fluorescence intensities for CD44 on CD8 + CD90.1 + OT-I T cells.</s><s>(B) Cell numbers were normalized to the mean values determined in treated Rag -/mice and are shown as relative (rel.)</s><s>values.</s><s>Data (±SEM) from 3 independent experiments with a total of 9-19 mice/ group are shown.</s><s>(EPS) S2 Fig. IL-7 administration decreases host il-7 expression.</s><s>(A, B) IL-representative mouse before (0h) and 24 hours (24h) after IL-7 treatment are shown.</s><s>(B) BLI levels measured at 24h were calculated in relation to those determined before treatment and relative BLI (rel.</s><s>BLI) values were calculated.</s><s>Shown are pooled data (± SEM) of 2 experiments with a total of 6 mice.</s><s>Statistical analysis was performed using Wilcoxon matched-pairs signed rank test.</s><s>(EPS)</s></p></div></figDesc></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">PLOS ONE | DOI:10.1371/journal.pone.0159690July 22, 2016  </note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments</head><p><s>We thank M. Pfau, C. Klatt, D. Femerling, J. Winckler and E. Denks for excellent technical assistance and T. Kammertoens for discussion.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author Contributions</head><p><s>Conceived and designed the experiments: KD TS.</s><s>Performed the experiments: KD DS UB.</s><s>Analyzed the data: KD TS.</s><s>Contributed reagents/materials/analysis tools: TB.</s><s>Wrote the paper: KD TS.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Maintaining the norm: T-cell homeostasis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Jameson</surname></persName>
		</author>
		<idno type="PMID">12154374</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="547" to="556" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Interleukin-7 receptor expression: intelligent design</title>
		<author>
			<persName><forename type="first">R</forename><surname>Mazzucchelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Durum</surname></persName>
		</author>
		<idno type="PMID">17259970</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="144" to="154" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Napolitano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Grant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Deeks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Rosa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Herzenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename></persName>
		</author>
		<idno type="PMID">11135619</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="73" to="79" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Interleukin 7 signaling in dendritic cells regulates the homeostatic proliferation and niche size of CD4+ T cells</title>
		<author>
			<persName><forename type="first">M</forename><surname>Guimond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Veenstra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Grindler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Cui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Murphy</surname></persName>
		</author>
		<idno type="DOI">10.1038/ni.1695</idno>
		<idno type="PMID">19136960</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="149" to="157" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Bevan MJ Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Goldrath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">Y</forename><surname>Bogatzki</surname></persName>
		</author>
		<idno type="PMID">10952725</idno>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">192</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="557" to="564" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Restifo NP Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Klebanoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Khong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Antony</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Palmer</surname></persName>
		</author>
		<idno type="PMID">15668127</idno>
	</analytic>
	<monogr>
		<title level="j">Trends Immunol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="111" to="117" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Adoptive immunotherapy for cancer or viruses</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Maus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Fraietta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Levine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kalos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>June</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Immunol</title>
		<imprint>
			<biblScope unit="page" from="32189" to="32225" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">et al T cell homeostatic proliferation elicits effective antitumor autoimmunity</title>
		<author>
			<persName><forename type="first">W</forename><surname>Dummer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Niethammer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Baccala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Lawson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Reisfeld</surname></persName>
		</author>
		<idno type="PMID">12122110</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="185" to="192" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<title level="m" type="main">Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing. Cancer Res</title>
		<author>
			<persName><forename type="first">L-X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>O'hara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Chu</surname></persName>
		</author>
		<idno type="PMID">16288050</idno>
		<imprint>
			<date type="published" when="2005">2005</date>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="10569" to="10577" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells</title>
		<author>
			<persName><forename type="first">L</forename><surname>Gattinoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Finkelstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Klebanoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Antony</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Palmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Spiess</surname></persName>
		</author>
		<idno type="PMID">16203864</idno>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">202</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="907" to="912" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Commensal microflora and interferon-gamma promote steady-state interleukin-7 production in vivo</title>
		<author>
			<persName><forename type="first">S</forename><surname>Shalapour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Deiser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Sercan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tuckermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Minnich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Willimsky</surname></persName>
		</author>
		<idno type="DOI">10.1002/eji.201040441</idno>
		<idno type="PMID">20690180</idno>
	</analytic>
	<monogr>
		<title level="j">Eur J Immunol</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="2391" to="2400" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Interleukin-7 links T lymphocyte and intestinal epithelial cell homeostasis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Shalapour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Deiser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Kühl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Glauben</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Krug</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fischer</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0031939</idno>
		<idno type="PMID">22384106</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">e31939</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Pellegrini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Calzascia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Elford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shahinian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Dissanayake</surname></persName>
		</author>
		<idno type="DOI">10.1038/nm.1953</idno>
		<idno type="PMID">19396174</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="528" to="536" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Mackall CL Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Cui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Meadors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Poon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Guimond</surname></persName>
		</author>
		<idno type="DOI">10.1182/blood-2009-03-212134</idno>
		<idno type="PMID">19704119</idno>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="3831" to="3840" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Thompson CB IL-7 enhances the survival and maintains the size of naive T cells</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Rathmell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Farkash</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Gao</surname></persName>
		</author>
		<idno type="PMID">11739504</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">167</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="6869" to="6876" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<author>
			<persName><forename type="first">G</forename><surname>Cui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Staron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Gray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P-C</forename><surname>Ho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Amezquita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wu</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cell.2015.03.021</idno>
		<idno type="PMID">25957683</idno>
	</analytic>
	<monogr>
		<title level="m">Glycerol Transport and TAG Synthesis Promotes Memory CD8(+) T Cell Longevity</title>
				<imprint>
			<date type="published" when="2015">2015</date>
			<biblScope unit="volume">161</biblScope>
			<biblScope unit="page" from="750" to="761" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Grabstein KH Regulation of human T cell proliferation by IL-7</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Armitage</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Namen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Sassenfeld</surname></persName>
		</author>
		<idno type="PMID">2295821</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="938" to="941" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Widmer MB Regulation of T cell proliferation by IL-7</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Grabstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Namen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Shanebeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Voice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Reed</surname></persName>
		</author>
		<idno type="PMID">1969881</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="3015" to="3020" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Durum SK IL-7 promotes T cell proliferation through destabilization of p27Kip1</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">Q</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Aleem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kaldis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Khaled</surname></persName>
		</author>
		<idno type="PMID">16492801</idno>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">203</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="573" to="582" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Lefrancois L Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Schluns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Kieper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Jameson</surname></persName>
		</author>
		<idno type="PMID">11062503</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="426" to="432" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Gress RE Harnessing the biology of IL-7 for therapeutic application</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Mackall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Fry</surname></persName>
		</author>
		<idno type="DOI">10.1038/nri2970</idno>
		<idno type="PMID">21508983</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="330" to="342" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Mackall CL Adjuvant IL-7 or IL-15 overcomes immunodominance and improves survival of the CD8+ memory cell pool</title>
		<author>
			<persName><forename type="first">F</forename><surname>Melchionda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Fry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Milliron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Mckirdy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tagaya</surname></persName>
		</author>
		<idno type="PMID">15841203</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1177" to="1187" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">et al IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancer</title>
		<author>
			<persName><forename type="first">A</forename><surname>Andersson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S-C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">K</forename><surname>Kar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Batra</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.0803340</idno>
		<idno type="PMID">19454692</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">182</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="6951" to="6958" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Novel function for interleukin-7 in dendritic cell development</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Vogt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Link</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Perrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Finke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Luther</surname></persName>
		</author>
		<idno type="DOI">10.1182/blood-2008-08-176321</idno>
		<idno type="PMID">19246338</idno>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="3961" to="3968" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Durum SK IL-7 induces myelopoiesis and erythropoiesis</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">B</forename><surname>Aiello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Keller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Klarmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Dranoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mazzucchelli</surname></persName>
		</author>
		<idno type="PMID">17237404</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">178</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1553" to="1563" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">X</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Keane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="PMID">11927620</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="931" to="937" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Blankenstein T Visualizing the dynamic of adoptively transferred T cells during the rejection of large established tumors</title>
		<author>
			<persName><forename type="first">J</forename><surname>Charo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Perez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Buschow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jukica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Czeh</surname></persName>
		</author>
		<idno type="DOI">10.1002/eji.201141452</idno>
		<idno type="PMID">21898380</idno>
	</analytic>
	<monogr>
		<title level="j">Eur J Immunol</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="3187" to="3197" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">IFN-γ Regulates CD8+ Memory T Cell Differentiation and Survival in Response to Weak, but Not Strong, TCR Signals</title>
		<author>
			<persName><forename type="first">D</forename><surname>Stoycheva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Deiser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Stärck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Nishanth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Schlüter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Uckert</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.1402058</idno>
		<idno type="PMID">25480562</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">194</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="553" to="559" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Surh CD IL-7/anti-IL-7 mAb complexes restore T cell development and induce homeostatic T Cell expansion without lymphopenia</title>
		<author>
			<persName><forename type="first">O</forename><surname>Boyman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ramsey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sprent</surname></persName>
		</author>
		<idno type="PMID">18490726</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">180</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="7265" to="7275" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4</title>
		<author>
			<persName><forename type="first">A</forename><surname>Vella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Teague</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ihle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kappler</surname></persName>
		</author>
		<idno type="PMID">9221762</idno>
	</analytic>
	<monogr>
		<title level="j">Marrack P Interleukin</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="325" to="330" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note>J Exp Med</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">Q</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">Q</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">B</forename><surname>Aiello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mazzucchelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Asefa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Khaled</surname></persName>
		</author>
		<idno type="PMID">15996891</idno>
	</analytic>
	<monogr>
		<title level="j">Cytokine Growth Factor Rev</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="513" to="533" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>Cell biology of IL</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Suppression of IL7Ral-pha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Erman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Appelbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Montoya-Durango</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Grimes</surname></persName>
		</author>
		<idno type="PMID">15308108</idno>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="289" to="302" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Ahmed R Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Kaech</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Wherry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">T</forename><surname>Konieczny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Surh</surname></persName>
		</author>
		<idno type="PMID">14625547</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1191" to="1198" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Weissman IL Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice</title>
		<author>
			<persName><forename type="first">K</forename><surname>Akashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kondo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Von Freeden-Jeffry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Murray</surname></persName>
		</author>
		<idno type="PMID">9215626</idno>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1033" to="1041" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">et al IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology</title>
		<author>
			<persName><forename type="first">M</forename><surname>Pellegrini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Calzascia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Toe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Preston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Elford</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cell.2011.01.011</idno>
		<idno type="PMID">21295337</idno>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="601" to="613" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Injection of glycosylated recombinant simian IL-7 provokes rapid and massive T-cell homing in rhesus macaques</title>
		<author>
			<persName><forename type="first">S</forename><surname>Beq</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rozlan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gautier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Mersseman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schilte</surname></persName>
		</author>
		<idno type="DOI">10.1182/blood-2008-11-191288</idno>
		<idno type="PMID">19351957</idno>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="816" to="825" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Coreceptor tuning&apos;: cytokine signals transcriptionally tailor CD8 coreceptor expression to the self-specificity of the TCR</title>
		<author>
			<persName><forename type="first">J-H</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Adoro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Lucas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Sarafova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Alag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Doan</surname></persName>
		</author>
		<idno type="PMID">17873878</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1049" to="1059" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Restifo NP CD8+ T-cell memory in tumor immunology and immunotherapy</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Klebanoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gattinoni</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol Rev</title>
		<imprint>
			<biblScope unit="page" from="211214" to="211224" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Restifo NP Paths to stemness: building the ultimate antitumour T cell</title>
		<author>
			<persName><forename type="first">L</forename><surname>Gattinoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Klebanoff</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrc3322</idno>
		<idno type="PMID">22996603</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Cancer</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="671" to="684" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Jung S CD11chigh dendritic cell ablation impairs lymphopenia-driven proliferation of naive and memory CD8+ T cells</title>
		<author>
			<persName><forename type="first">T</forename><surname>Zaft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sapoznikov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Krauthgamer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Littman</surname></persName>
		</author>
		<idno type="PMID">16272295</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">175</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="6428" to="6435" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Amigorena S Cross-presentation by dendritic cells</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">P</forename><surname>Joffre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Segura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Savina</surname></persName>
		</author>
		<idno type="DOI">10.1038/nri3254</idno>
		<idno type="PMID">22790179</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="557" to="569" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Regulation of T cell-dendritic cell interactions by IL-7 governs T-cell activation and homeostasis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Saini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pearson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Seddon</surname></persName>
		</author>
		<idno type="DOI">10.1182/blood-2008-12-192252</idno>
		<idno type="PMID">19357399</idno>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="5793" to="5800" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Bystander elimination of antigen loss variants in established tumors</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Spiotto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Rowley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Schreiber</surname></persName>
		</author>
		<idno type="PMID">14981514</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="294" to="298" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">IL-7 signaling must be intermittent, not continuous, during CD8 + T cell homeostasis to promote cell survival instead of cell death</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Y</forename><surname>Kimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Pobezinsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">I</forename><surname>Guinter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Adams</forename><forename type="middle">A</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-H</forename></persName>
		</author>
		<idno type="DOI">10.1038/ni.2494</idno>
		<idno type="PMID">23242416</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="143" to="151" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Use of interleukin 7 receptor-α knockout donor cells demonstrates the lymphoid independence of dendritic cells</title>
		<author>
			<persName><forename type="first">S</forename><surname>Takeuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Katz</surname></persName>
		</author>
		<idno type="PMID">16166595</idno>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="184" to="186" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells</title>
		<author>
			<persName><forename type="first">A</forename><surname>Link</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Vogt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Favre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Britschgi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Acha-Orbea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hinz</surname></persName>
		</author>
		<idno type="PMID">17893676</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1255" to="1265" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes</title>
		<author>
			<persName><forename type="first">M</forename><surname>Watanabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ueno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yajima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Iwao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tsuchiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ishikawa</surname></persName>
		</author>
		<idno type="PMID">7769137</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2945" to="2953" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Interleukin 7 is produced by murine and human keratinocytes</title>
		<author>
			<persName><forename type="first">C</forename><surname>Heufler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Topar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Grasseger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Stanzl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Koch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Romani</surname></persName>
		</author>
		<idno type="PMID">8350050</idno>
	</analytic>
	<monogr>
		<title level="j">J Exp Med</title>
		<imprint>
			<biblScope unit="volume">178</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1109" to="1114" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Hepatic interleukin-7 expression regulates T cell responses</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Sawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Arima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ogura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kitabayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-J</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fukushima</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.immuni.2009.01.007</idno>
		<idno type="PMID">19285437</idno>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="447" to="457" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Harada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yamamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Okamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Morita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kawashima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Aita</surname></persName>
		</author>
		<idno type="PMID">10403280</idno>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1508" to="1516" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Interleukin-7 is produced by afferent lymphatic vessels and supports lymphatic drainage</title>
		<author>
			<persName><forename type="first">M</forename><surname>Iolyeva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Aebischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Proulx</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A-H</forename><surname>Willrodt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ecoiffier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Häner</surname></persName>
		</author>
		<idno type="DOI">10.1182/blood-2013-01-478073</idno>
		<idno type="PMID">23963040</idno>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="2271" to="2281" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Mutually exclusive regulation of T cell survival by IL-7R and antigen receptor-induced signals</title>
		<author>
			<persName><forename type="first">P</forename><surname>Koenen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Heinzel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Carrington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Happo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Alexander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1038/ncomms2719</idno>
		<idno type="PMID">23591902</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Commun</title>
		<imprint>
			<biblScope unit="page">41735</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
